2025-01-07 - Analysis Report
## Intuitive Surgical Inc. (ISRG) Stock Report

**1. Performance Summary & Comparison to S&P 500 (VOO):**

Intuitive Surgical Inc. is a company that manufactures and sells da Vinci surgical systems and related instruments and accessories.

The cumulative return of ISRG is significantly higher than the S&P 500 (VOO).  The difference in cumulative returns as of the last data point is 178.0%, placing it at the 94.7th percentile of its historical range compared to the S&P 500.  This indicates a substantial outperformance. The provided alpha values are consistently 0, which could be due to the methodology used in the calculation or limitation of the data set provided. The beta values show high volatility and correlation to the market.


**2. Recent Price Movement:**

* **Closing Price:** $542.37
* **5-Day Moving Average:** $530.12
* **20-Day Moving Average:** $535.29
* **60-Day Moving Average:** $526.01

The price is currently above all three moving averages, suggesting a potential short-term uptrend.


**3. Technical Indicators & Expected Return:**

* **RSI:** 51.77 (Slightly above neutral; neither overbought nor oversold)
* **PPO:** -0.06 (Slightly negative, suggesting bearish momentum)
* **Relative Strength:** Positive recent change (+2.0), indicating short-term upward momentum.
* **Expected Return (Long-Term):** 18.9% above S&P 500 over two years or more with consistent investment.  The provided 542.37 price does not suggest a significant recent price jump or drop, therefore does not require further analysis.


**4. Recent Earnings Analysis:**

The provided earnings data shows a generally increasing trend in both revenue and EPS, although there is some fluctuation between quarters.  The latest quarter (2024-10-18) shows a slight decrease in EPS compared to the previous quarter (2024-07-19), but revenue remained relatively stable.  There is no information provided about whether these results beat or missed expectations.



**5. Financial Information Analysis:**

**Revenue and Profitability:** Revenue shows consistent growth and high profit margins above 65%.  A slight dip is observed at the end of 2023, followed by a recovery.

**Capital and Profitability:** Equity is steadily increasing, demonstrating strong financial health. ROE fluctuates slightly, but generally remains healthy.


**6. News and Recent Issues:**

No information about recent earnings news (within the last two days), market outlook, or analyst opinions is provided.  This section requires additional information.


**7. Overall Analysis:**

ISRG has shown significant outperformance against the S&P 500 over the provided period.  While recent technical indicators show mixed signals (RSI slightly above neutral, PPO slightly negative), the long-term expected return is positive.  The company demonstrates strong revenue growth and profitability.  However, a more comprehensive analysis requires additional data, especially recent news, analyst opinions, and a comparison of reported earnings to expectations.  The lack of information on analyst predictions and news in the last 48 hours limits the scope of this analysis.  Further investigation into those areas is highly recommended before making investment decisions.


**8. Disclaimer:** This report is based solely on the limited data provided. It does not constitute financial advice.  Conduct thorough research and consult with a financial professional before making any investment decisions.
